Accordingly, these findings present the valuable capabilities of albumin and suggest that CNS-targeted drug delivery might be possible through nasal route application by utilizing serum albumin as a carrier system to deliver the drug for the treatment of neurological diseases [53,54]. The gene discussed is ALB; the disease is nervous system disorder.